Fifty-two and fifty-three weeks ended | | February 1, 2014 | | February 2, 2013 | |
| | | | | |
Cash flows from operating activities: | | | | | |
Net earnings | | $ | 6,865 | | $ | 12,810 | |
Adjustments to reconcile net earnings to net cash provided by continuing operations: | | | | | |
Net loss from discontinued operations | | 188 | | 345 | |
Depreciation | | 78,439 | | 79,104 | |
Amortization of deferred gain from asset sales | | (12,604 | ) | (12,846 | ) |
Amortization of deferred financing costs | | 2,993 | | 4,431 | |
Stock compensation expense | | 2,992 | | 1,299 | |
Deferred income taxes | | (79 | ) | 7,576 | |
Net loss (gain) from dispositions of assets | | 227 | | (1,323 | ) |
Loss from asset impairment | | 7,659 | | 10,555 | |
Other | | (493 | ) | (269 | ) |
Changes in assets and liabilities, net of the effects of acquisitions: | | | | | |
Increase in accounts receivable, prepaid expenses and other | | (6,511 | ) | (602 | ) |
Increase in merchandise inventories | | (31,146 | ) | (27,074 | ) |
Increase in accounts payable | | 8,378 | | 984 | |
Increase in accrued expenses | | 6,115 | | 10,481 | |
(Decrease) increase in other long-term liabilities | | (3,345 | ) | 3,487 | |
Net cash provided by continuing operations | | 59,678 | | 88,958 | |
Net cash used in discontinued operations | | (274 | ) | (467 | ) |
Net cash provided by operating activities | | 59,404 | | 88,491 | |
| | | | | |
Cash flows from investing activities: | | | | | |
Capital expenditures | | (53,982 | ) | (54,696 | ) |
Proceeds from dispositions of assets | | 21 | | 5,588 | |
Cash paid for acquisitions | | (10,694 | ) | — | |
Additions to collateral investment | | (2,312 | ) | (3,654 | ) |
Release of collateral investment | | 1,650 | | — | |
Net cash used in investing activities | | (65,317 | ) | (52,762 | ) |
| | | | | |
Cash flows from financing activities: | | | | | |
Borrowings under line of credit agreements | | 40,745 | | 2,319 | |
Payments under line of credit agreements | | (37,245 | ) | (2,319 | ) |
Borrowings on trade payable program liability | | 154,985 | | 179,751 | |
Payments on trade payable program liability | | (174,902 | ) | (115,247 | ) |
Payment for finance issuance cost | | (770 | ) | (6,520 | ) |
Borrowings under new debt | | — | | 200,000 | |
Debt payments | | (2,000 | ) | (295,122 | ) |
Proceeds from stock issuance | | 2,095 | | 2,693 | |
Repurchase of common stock | | (2,750 | ) | (342 | ) |
Net cash used in financing activities | | (19,842 | ) | (34,787 | ) |
Net (decrease) increase in cash and cash equivalents | | (25,755 | ) | 942 | |
Cash and cash equivalents at beginning of period | | 59,186 | | 58,244 | |
Cash and cash equivalents at end of period | | $ | 33,431 | | $ | 59,186 | |
| | | | | |
Supplemental cash flow information: | | | | | |
Cash paid for income taxes | | $ | 4,377 | | $ | 2,826 | |
Cash received from income tax refunds | | 1,251 | | 108 | |
Cash paid for interest | | 12,027 | | 31,290 | |
Accrued purchases of property and equipment | | 3,467 | | 1,371 | |